Over a period of 25 years we have developed extensive experience in assays related to diabetes.
We have been involved in assay development, validation and using these assays for measurement of hormone levels in a variety of clinical situations such as clinical trials, research into the relative roles of insulin secretion and insulin resistance and also for the diagnosis of hypoglycaemic states such as insulinoma and factitious hypoglycaemia. This has led to numerous publications in the areas of assay methodology and the pathophysiology of type 2 diabetes. The work has also led to numerous contacts and work with the pharmaceutical industry.
Although a number of companies provide central laboratory services to the pharmaceutical industry, these companies may lack in-depth clinical knowledge of diabetes and are often not familiar with recent developments in novel treatments for diabetes, such as post-prandial glucose regulators and insulin analogues.
We therefore aim to provide a high quality service specialising in assays relevant to diabetes and endocrinology research.
The laboratories have recently relocated to state of the art facilities in the Grove Building Swansea University.
The laboratories are accredited to Good Clinical and Laboratory Practice standards.